Practical Elements of a Radiopharmaceutical Program: Findings from ASTRO's Safety White Paper
Despite the rapid advancements, there exists a gap in the integration of radiopharmaceutical therapy within radiation oncology practices.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
ASTRO/SNMMI Joint Session: Unlocking Success in Radiopharmaceutical Therapy: Collaboration between Radiation Oncology, Nuclear Medicine and Industry
Theranostics, a treatment paradigm pairing diagnostic molecular imaging with radiopharmaceutical therapy (RPT), is resurgent, mainly driven by the FDA approvals of 177Lu-dotatate for neuroendocrine tumors and 177Lu-PSMA-617 for prostate cancer.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Precision in Practice: The Critical Role of Radiation Dosimetry in Radiotherapeutic Pharmaceuticals
Radiation dosimetry plays a critical role in the development and application of radiotherapeutic pharmaceuticals, ensuring both efficacy and safety in treatment.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Moving Beyond the Basics: Implementation of a Radiopharmaceutical Therapy Program - RPT Workshop 2025
Radiopharmaceuticals are an increasingly utilized therapeutic option for the treatment of malignancies.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 4.50 AMA PRA Category 1 Credit™
  • 4.50 Certificate of Attendance
Cost $379.00
Leveraging Anti-Tumor Immunity with Radiopharmaceutical Therapy (RPT) and Potential Combinatorial Approaches with RPT and Immunotherapy
Radiopharmaceutical Therapy (RPT) is an emerging modality with significant potential to impact future oncological management across many disease settings.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
2026 Multidisciplinary Radiopharmaceutical Therapy Symposium onDemand
The 2026 Multidisciplinary Radiopharmaceutical Therapy Symposium is a two-day meeting featuring interactive and case-based educational sessions that focus on the evolving utilization of and advancements in radiopharmaceuticals in the treatment of cancer and other indications.
Category
  • Radiopharmaceutical Therapy
Format
  • Meetings onDemand
Credits
  • 13.25 AMA PRA Category 1 Credit™
  • 13.25 Certificate of Attendance
Cost $1,799.00
Radiopharmaceutical Therapies: 177Lu-Dotatate and 177Lu-PSMA-617
Radiopharmaceutical therapies have been a breakthrough cancer treatment for tumors resistant to cytotoxic chemotherapy and many new radiopharmaceutical agents are in active development.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $149.00
Theranostics in Practice: From Program Requirements to Therapy-Ready Solutions [ASTRO Industry-Sponsored Webinar onDemand]
Radiation oncology is playing an increasingly important role in theranostics—but building a successful program requires more than clinical interest alone.
Category
  • Radiopharmaceutical Therapy
  • Physics
Format
  • Sessions onDemand
Credits
Cost $0.00
Beyond the Beam 2.0: An Updated Radiation Oncology Curriculum for Radiopharmaceutical Therapy
Beyond the Beam 2.0 updates the original 2024 curriculum. This in-depth curriculum supplement resource is designed specifically for radiation oncology residents and practicing radiation oncologists who are planning or participating in a radiopharmaceutical therapy (RPT) clinical program.
Category
  • Radiopharmaceutical Therapy
  • Radiobiology
  • Physics
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 14.00 AMA PRA Category 1 Credit™
  • 14.00 Certificate of Attendance
Cost $799.00
ASTRO's Authorized User Training Program for Radiopharmaceutical Therapy Application
ASTRO’s AU Training Program provides radiation oncologists with a comprehensive, hands-on experience to meet Nuclear Regulatory Commission (NRC) and Agreement State requirements for Authorized User (AU) status in radiopharmaceutical therapy (RPT).
Category
  • Radiopharmaceutical Therapy
Format
Credits
Cost $0.00